Strategic Advisor, Precision Medicine
Actual Labs Consulting
Phoenix, Arizona, United States
Dr. William Hendricks is a translational scientist focused on bringing precision medicine approaches into real-world clinical use across veterinary and human health. His work has centered on cancer genomics, precision diagnostics and therapetuics, and comparative oncology across academia and industry, including co-founding one of the first canine precision oncology companies. He is especially interested in how genomic and multi-omic tools can move beyond discovery and become practical, clinically useful resources for veterinarians and their patients. He currently serves as Strategic Advisor to CanCan Diagnostics and Chief Product Officer at MI:RNA Diagnostics.
Disclosure(s): CanCan Diagnostics: Advisor (Ongoing); Kyrexa: Advisor (Ongoing); MI:RNA Diagnostics: Fractional Chief Product Officer; fees, equity options (Ongoing); Strategic Healthcare Advisors: Advisor (Ongoing)
Panel: Omics-Driven Precision Medicine in Canine Oncology
Friday, June 12, 2026
1:30 PM - 3:45 PM PT